PT - JOURNAL ARTICLE AU - Browning, Sean AU - Lee, Scott H. AU - Belay, Ermias AU - DeCuir, Jennifer AU - Cato, Shana Godfred AU - Patel, Pragna AU - Schwartz, Noah AU - Wong, Karen K. TI - Evaluation of machine learning for predicting COVID-19 outcomes from a national electronic medical records database AID - 10.1101/2022.04.13.22273835 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.13.22273835 4099 - http://medrxiv.org/content/early/2022/04/14/2022.04.13.22273835.short 4100 - http://medrxiv.org/content/early/2022/04/14/2022.04.13.22273835.full AB - Objective When novel diseases such as COVID-19 emerge, predictors of clinical outcomes might be unknown. Using data from electronic medical records (EMR) allows evaluation of potential predictors without selecting specific features a priori for a model. We evaluated different machine learning models for predicting outcomes among COVID-19 inpatients using raw EMR data.Materials and Methods In Premier Healthcare Data Special Release: COVID-19 Edition (PHD-SR COVID-19, release date March, 24 2021), we included patients admitted with COVID-19 during February 2020 through April 2021 and built time-ordered medical histories. Setting the prediction horizon at 24 hours into the first COVID-19 inpatient visit, we aimed to predict intensive care unit (ICU) admission, hyperinflammatory syndrome (HS), and death. We evaluated the following models: L2-penalized logistic regression, random forest, gradient boosting classifier, deep averaging network, and recurrent neural network with a long short-term memory cell.Results There were 57,355 COVID-19 patients identified in PHD-SR COVID-19. ICU admission was the easiest outcome to predict (best AUC=79%), and HS was the hardest to predict (best AUC=70%). Models performed similarly within each outcome.Discussion Although the models learned to attend to meaningful clinical information, they performed similarly, suggesting performance limitations are inherent to the data.Conclusion Predictive models using raw EMR data are promising because they can use many observations and encompass a large feature space; however, traditional and deep learning models may perform similarly when few features are available at the individual patient level.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the Centers for Disease Control and Prevention waived ethical approval for this work because the disclosed Premier Healthcare Database Special COVID-19 Release data are considered de-identified.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available from Premier Inc. as the PINC-AI Healthcare Data Special Release: COVID-19. https://offers.premierinc.com/PINC-AI-Healthcare-Data-COVID-Whitepaper-LandingPage.html